What do Emergency Physicians Know About Immune Checkpoint Inhibitor-Related Toxicities: A Brief Report

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Butters Thomas; Liu Wing Kin; Grant Michael; Jackson Spence Francesca; Zaynub Ghufoor; So Alfred; Lam James; Ashfar Mehran; Enting Deborah; Powles Thomas; Szabados Bernadett

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: International Journal of Cancer Management Year:2021 | Volume:14 | Issue:8 Page(s): 0-0

Download Full-Text

View:

136

Download:

Cites:

Information Journal Paper

Title

What do Emergency Physicians Know About Immune Checkpoint Inhibitor-Related Toxicities: A Brief Report

Author(s)

Keywords

Acute Oncology

Emergency Medicine

Cancer Immunotherapy

Abstract

Background: Cancer types eligible for treatment withimmunecheckpoint inhibitors (ICI) have increased over the past decade thus simultaneously growing the number of patients presenting to emergency departments (ED) with immune mediated toxicities. Objectives: The objective of this study was to ascertain information regarding the knowledge and management of immune checkpoint inhibitor mediated toxicities amongst emergency department physicians. Methods: A multiple-choice questionnaire was developed assessing the understanding of ICI usage and management of immune mediated toxicities, amongst ED physicians in 6 major ED departments in London. Participating clinicians included all levels of trainees and ED physicians. Questionnaires were distributed during weekly ED educational sessions, followed by training on immune-mediated toxicities. Results: Between March 2019 and September 2019, the questionnaire was delivered to 126 participants (80% junior grade, 20% specialist ED consultants). There was no significant association between clinician’ s seniority and overall score reached on the questionnaire. Amongst all participants, 56, 49, and 36% identified correctly ICIs as the first-line treatment regimen for melanoma, renal cell carcinoma, and non-small cell lung cancer, respectively. Overall, 90% of the participants recognized correctly cisplatin as a chemotherapy agent and 77% pembrolizumab as an ICI agent. Generally, there was a good understanding of chemotherapy related toxicities, however, the participants scored less well on questions relating to ICIs. Ten months following the initial audit and educational intervention, a single site re-audit was performed. The total average correct score was similar pre-and post-intervention (8, 13%, respectively). Conclusions: Knowledgeandmanagementof immunemediated toxicities is inferiorcomparedtochemotherapyacross physicians working in major ED departments in London. This survey highlights the need for increased education on ICI amongst ED clinicians.

Cites

No record.

References

No record.

Cite

APA: Copy

Butters, Thomas, Liu, Wing Kin, Grant, Michael, Jackson Spence, Francesca, Zaynub, Ghufoor, So, Alfred, Lam, James, Ashfar, Mehran, Enting, Deborah, Powles, Thomas, & Szabados, Bernadett. (2021). What do Emergency Physicians Know About Immune Checkpoint Inhibitor-Related Toxicities: A Brief Report. INTERNATIONAL JOURNAL OF CANCER MANAGEMENT (IRANIAN JOURNAL OF CANCER PREVENTION), 14(8), 0-0. SID. https://sid.ir/paper/690047/en

Vancouver: Copy

Butters Thomas, Liu Wing Kin, Grant Michael, Jackson Spence Francesca, Zaynub Ghufoor, So Alfred, Lam James, Ashfar Mehran, Enting Deborah, Powles Thomas, Szabados Bernadett. What do Emergency Physicians Know About Immune Checkpoint Inhibitor-Related Toxicities: A Brief Report. INTERNATIONAL JOURNAL OF CANCER MANAGEMENT (IRANIAN JOURNAL OF CANCER PREVENTION)[Internet]. 2021;14(8):0-0. Available from: https://sid.ir/paper/690047/en

IEEE: Copy

Thomas Butters, Wing Kin Liu, Michael Grant, Francesca Jackson Spence, Ghufoor Zaynub, Alfred So, James Lam, Mehran Ashfar, Deborah Enting, Thomas Powles, and Bernadett Szabados, “What do Emergency Physicians Know About Immune Checkpoint Inhibitor-Related Toxicities: A Brief Report,” INTERNATIONAL JOURNAL OF CANCER MANAGEMENT (IRANIAN JOURNAL OF CANCER PREVENTION), vol. 14, no. 8, pp. 0–0, 2021, [Online]. Available: https://sid.ir/paper/690047/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops